HIV care providers' implementation of routine alcohol reduction support for their patients

AIDS Patient Care and STDs

Volumn 23, Issue 3, 2009, Pages 211-218

  Strauss, Shiela M ^a,d   Tiburcio, Nelson J ^c   Munoz Plaza, Corrine ^c   Gwadz, Marya ^c   Lunievicz, Joseph ^c   Osborne, Andrew ^c   Padilla, Diana ^c   Arias, Mary McCarty ^c   Norman, Robert ^b  

^a School of Nursing   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ARTICLE; DATA ANALYSIS; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT CARE PLANNING; SCREENING TEST; SOCIAL SUPPORT; UNITED STATES;

ALCOHOL DRINKING; BEHAVIOR THERAPY; COUNSELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; MALE; NEW YORK CITY; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR;

EID: 63149169049     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0008     Document Type: Article

References (54)

1. Bryant KJ. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse 2006;41:1465-1507.
2. Conigliaro J, Madenwald T, Bryant K, et al. The Veterans Aging Cohort Study: Observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus-infected veterans. Alcohol Clin Exp Res 2004;28:313-321.
3. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system: A review. Alcohol Clin Exp Res 1998;22:1927-1942.
4. Meyerhoff DJ. Effects of alcohol and HIV infection on the central nervous system. Alcohol Res Health 2001;25:288-298.
5. Palepu A, Raj A, Horton NJ, Tibbetts N, Meli S, Samet JH. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat 2005;28:3-9.
6. Parsons JT, Vicioso K, Kutnick A, Punzalan JC, Halkitis PN, Velasquez MM. Alcohol use and stigmatized sexual practices of HIV seropositive gay and bisexual men. Addict Behav 2004;29:1045-1051.
7. Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res 2005;29:837-843.
8. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
9. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of non-adherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003;114:573-580.
10. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111-1117.
11. Parruti G, Manzoli L, Toro PM, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: Predictors and impact on virologic response and relapse. AIDS Patient Care STDs 2006;20:48-56.
12. Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 2005;29:1190-1197.
13. Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004;16:219-230.
14. Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res 2004;28:572-577.
15. Benhamou Y, Bochet M, DiMartino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999;30:1054-1058.
16. Prakash O, Mason A, Luftig RB, Bautista AP. Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics. Front Biosci 2002;7:e286-300.
17. Pol S, Lamorthe B, Thi NT, et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998;28:945-950.
18. Centers for Disease Control and Prevention (CDC); Health Resources and Services Administration; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003;52:1-24.
19. Morin SF, Koester KA, Steward WT, et al. Missed opportunities: Prevention with HIV-infected patients in clinical care settings. J Acquire Immune Defic Syndr 2005;36:960-966.
20. Gerbert B, Danley DW, Herzig K, et al. Reframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients. AIDS Patient Care STDs 2006;20:19-29.
21. Mitchell CG, Perloff J, McVicker J, Ebbert S, Petersen L, Oltean A. Integrating prevention in residential and community care settings: A multidimensional program evaluation. AIDS Educ Prev 2005;17(Suppl A):89-101.
22. Grodensky CA, Golin CE, Boland MS, Patel SN, Quinlivan EB, Price M. Translating concern into action: HIV care providers' views on counseling patients about HIV prevention in the clinical setting. AIDS Behav 2008;12:404-411.
23. Metsch LR, Pereyra M, del Rio C, et al. Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health 2004;94:1186-1192.
24. Wilson TE, Vlahov D, Crystal S, et al. Integrating HIV prevention activities into the HIV medical care setting: A report from the NYC HIV Centers Consortium. J Urban Health 2006;83:18-30.
25. Chillag K, Bartholow K, Cordeiro J, et al. Factors affecting the delivery of HIV/AIDS prevention programs by community-based organizations. AIDS Educ Prev 2002;14(3 Suppl A):27-37.
26. Sebesta DS, Marx R, Liu Y. HIV prevention case management in San Francisco: Barriers to successful implementation. AIDS Care 2006;18:345-355.
27. Bluespruce J, Dodge WT, Grothaus L, et al. HIV prevention in primary care: Impact of a clinical intervention. AIDS Patient Care STDS 2001;15:243-253.
28. Mitchell CG, Linsk NL. Prevention for positives: Challenges and opportunities for integrating prevention into HIV case management. AIDS Educ Prev 2001;13:393-402.
29. Fleming MF, Mundt MP, French MT, Manwell LB, Staauffacher EA, Barry KL. Brief physician advice for problem drinkers: Long-term efficacy and cost-benefit analysis. Alcohol Clin Exp Res 2002;26:36-43.
30. Bertholet N, Daeppen JB, Wietlisbach V, Fleming M, Burnand B. Reduction of alcohol consumption by brief alcohol intervention in primary care: Systematic review and meta-analysis. Arch Intern Med 2005;165:986-995.
31. Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 2002;26:272-279.
32. Maisto SA, Saitz R. Alcohol use disorders: Screening and diagnosis. Am J Addict 2003;12(Suppl 1):S12-S25.
33. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: A meta analytic review of controlled investigations in treatment-seeking and non treatment-seeking populations. Addiction 2002;97:279-292.
34. Fleming M, Manwell LB. Brief intervention in primary care settings: A primary treatment method for at-risk, problem, and dependent drinkers. Alcohol Res Health 1999;23:128-137.
35. Fleming MF. Strategies to increase alcohol screening in health care settings. Alcohol Health Res World 1997;21:340-347.
36. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Helping Patients Who Drink Too Much. A Clinician's Guide. http://pubs.niaaa.nih.gov/ publications/Practitioner/CliniciansGuide2005/guide.pdf (Last accessed January 23, 2009).
37. Babor T, Higgins-Biddle J, Higgins P, Gassman R, Gould B. Training medical providers to conduct alcohol screening and brief interventions. Subst Abus 2004;24:17-26.
38. Barta SK, Stacy RD. The effects of a theory-based training program on nurses' self-efficacy and behavior for smoking cessation counseling. J Contin Educ Nurs 2005;36:117-123.
39. Kviz FJ, Clark MA, Prohaska TR, et al. Attitudes and practices for smoking cessation counseling by provider type and patient age. Prev Med 1995;24:201-212.
40. Lane C, Huws-Thomas M, Hood K, Rollnick S, Edwards K, Robling M. Measuring adaptations of motivational interviewing: The development and validation of the behavior change counseling index (BECCI). Patient Educ Couns 2005;56:166-173.
41. Ockene J, Wheeler E, Adams A, Hurley T, Hebert J. Provider training for patient-centered alcohol counseling in a primary care setting. Arch Intern Med 1997;157:2334-2341.
42. Zapka J, Fletcher K, Ma Y, Pbert L. Physicians and smoking cessation. Eval Health Prof 1997;20:407-427.
43. Aalto M, Pekuri P, Seppa K. Primary health care nurses' and physicians' attitudes, knowledge and beliefs regarding a brief intervention for heavy drinkers. Addiction 2001;96:305-311.
44. Hudmon KS, Kroon LA, Corelli RL, et al. Training future pharmacists at a minority educational institution: Evaluation of the Rx for Change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev 2004;13:477-481.
45. Laschinger H, Tresolini C. An exploratory study of nursing and medical students health promotion counseling self-efficacy. Nurse Educ Today 1999;19:408-418.
46. Lorenz R, Gregory R, Davis D. Utility of a brief self-efficacy scale in clinical training program evaluation. Eval Health Prof 2000;23:182-193.
47. Poirier MK, Clark MM, Cerhan JH, Pruthi S, Geda YE, Dale LC. Teaching motivational interviewing to first-year medical students to improve counseling skills in health behavior change. Mayo Clin Proc 2004;79:327-331.
48. Mark TL, Kranzler HR, Song X. Understanding US addiction physicians' low rate of naltrexone prescription. Drug Alcohol Depend 2003;71:219-228.
49. Stajkovic AD, Luthans F. Self-efficacy and work-related performance: A meta-analysis. Psychol Bull 1998;124:240-261.
50. Myers JJ, Rose CD, Shade SB, Koester KA, Maiorana A, Malitz F, Steward WT, Morin SF. Sex, risk and responsibility: Provider attitudes and beliefs predict HIV transmission risk prevention counseling in clinical care settings. AIDS Behav 2007;11(5 Suppl):S30-38.
51. Callahan EJ, Flynn NM, Kuenneth CA, Enders SR. Strategies to reduce HIV risk behavior in HIV primary care clinics: Brief provider messages and specialist intervention. AIDS Behav 2007;11(5 Suppl):S48-57.
52. Koester KA, Maiorana A, Vernon K, Myers J, Rose CD, Morin S. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned. AIDS Behav 2007;1(5 Suppl):S17-29.
53. Nollen C, Drainoni ML, Sharp V. Designing and delivering a prevention project within an HIV treatment setting: lessons learned from a specialist model. AIDS Behav 2007;11(5 Suppl):S84-94.
54. Aharonovich E, Hatzenbuehler ML, Johnston B, et al. A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting. AIDS Care 2006;18:561-568.